about
Predictors of mortality in patients with Alzheimer's disease living in nursing homesCellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectivesBiomarkers for physical frailty and sarcopenia: state of the science and future developmentsAntithrombotic drugs in secondary stroke prevention among a community dwelling older populationCharacteristics of adults with down syndrome: prevalence of age-related conditionsHealth care for older persons in Italy.Playing piano in visuospatial neglect: a case studyValidity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.Physical function and self-rated health status as predictors of mortality: results from longitudinal analysis in the ilSIRENTE study.Interaction of HDL cholesterol concentrations on the relationship between physical function and inflammation in community-dwelling older persons.The comprehensive geriatric assessment: when, where, how.Sarcopenia and physical frailty: two sides of the same coinShorter telomeres in peripheral blood mononuclear cells from older persons with sarcopenia: results from an exploratory studyAssessment of nursing home residents in Europe: the Services and Health for Elderly in Long TERm care (SHELTER) studySkeletal muscle apoptotic signaling predicts thigh muscle volume and gait speed in community-dwelling older persons: an exploratory study.Pre-hospital dietary intake correlates with muscle mass at the time of fracture in older hip-fractured patientsPatterns of circulating inflammatory biomarkers in older persons with varying levels of physical performance: a partial least squares-discriminant analysis approach.Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individualsInappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly.Myeloperoxidase levels and mortality in frail community-living elderly individuals.Physical function, physical activity and recent falls. Results from the "Invecchiamento e Longevità nel Sirente (ilSIRENTE)" Study"The Memory of Beauty" Survives Alzheimer's Disease (but Cannot Help Memory).Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicentre survey. On behalf of the GIFA (SIGG-ONLUS) Investigators.Quality of care in European home care programs using the second generation interRAI Home Care Quality Indicators (HCQIs)Cu to Zn ratio, physical function, disability, and mortality risk in older elderly (ilSIRENTE study).Calorie restriction for optimal cardiovascular aging: the weight of evidenceLifetime occupation and physical function: a prospective cohort study on persons aged 80 years and older living in a community.Impact of an Innovative Educational Strategy on Medication Appropriate Use and Length of Stay in Elderly Patients.Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).Request for regulatory guidance for cancer cachexia intervention trials.Impact of physical function impairment and multimorbidity on mortality among community-living older persons with sarcopaenia: results from the ilSIRENTE prospective cohort studyAll-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort studyCase management, preventive strategies, and caregiver attitudes among older adults in home care: results of the ADHOC study.Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study.Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy.Omega-3 polyunsaturated fatty acids and depression: a review of the evidence.Systemic inflammation, body composition, and physical performance in old community-dwellers.Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy.The primary care physician and Alzheimer's disease: an international position paper.Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
P50
Q22242018-40CEBA80-D608-4906-A047-FDD33D777DCEQ24647295-BD6FEBBE-7F77-4487-8A95-1753420C0895Q26775328-482AB712-DB63-4C00-97A8-44E3D4747ACAQ28196830-F16A73C4-4E91-4699-94C2-3576F7000545Q28652311-1ABCE1A8-DF90-4A43-8441-559F30B3B34EQ30332274-D763A4AC-EA7F-4DBE-B288-6764ED5AE26DQ30538224-8878BFE7-CC83-4E15-A6EE-4FF9BC5D9038Q32113329-7F167F48-846D-4BFF-8CD5-16B7DFFF4928Q33395096-121596AB-C06C-4FDC-9306-3F92D37D4439Q33566579-6651905B-3E7A-4DED-A9BF-EADA1F025EEEQ33861566-5F296EBD-90B2-49CA-8507-9EF02B33DDB7Q33958411-4397C30B-36FA-46F7-8391-6151C345D519Q34102906-2D50A5AA-38EA-4094-967D-23AE048B915FQ34122240-DB3B02D0-8929-4540-9AA0-C1E8A58E1F28Q34184688-8D1103AC-55A0-4A6D-9AB5-E48EB9C66A15Q34537893-0BEF712C-1E54-4567-8BBF-23FB510FFC3DQ34931426-06BC6E4D-9482-4B92-B28F-2D040555192FQ35063932-889AE775-C188-428B-A154-3E4EABCC0A27Q35122806-4C8289AF-F6EF-4687-B036-820D9DAE2284Q35135381-8CE16163-B039-49E9-B2FE-54E39FCFE12FQ35206135-D90A7688-573E-4A16-89F0-D66506FB5E9BQ35536014-B8AA4ED5-D0EA-4E81-8945-F0A107CDE33DQ35572360-AD194670-5397-4338-9A0B-A63E1FE421BAQ35842658-474C58D8-5EC5-4F76-988E-7326B74E66FAQ35916426-CA0E854D-49F6-4A1F-8ABF-00F0ED8117F8Q36069412-0F57BD68-1AD2-4CA1-A15D-817B93509129Q36166442-A113B24E-B118-417F-9F8E-3BCE392CBCFFQ36194529-7F3805C6-6804-47D3-BE2A-526F8A3B1F93Q36220834-81F458A2-6AC3-4C30-8279-5437A677183AQ36349332-18CC0581-B3C3-42E0-954B-5B90805ED45DQ37134141-A40E5801-C6F7-4E7C-95A6-C33E4BCD75C0Q37177773-AB1B5E37-7AB7-4D02-B34D-47341BC31087Q37179751-8197B874-BFA0-431B-AAB5-CFC3071B079DQ37392912-B5CAF342-2C92-4636-82BC-46C6853DDF76Q37486939-E6AAEC78-17B6-40A6-96B3-48FEF5C6F2E9Q37664781-B1F33198-E11E-4E8A-AAF4-DD0CB8F34A2EQ37667488-C25B8F0D-FAB5-44A1-8AEC-F9058F8697D2Q37685562-913F403F-CD66-42EA-B7D1-259AC18E401AQ37686187-E08CFBBD-2032-4A05-AFB5-C2354C4E1454Q37725119-18D8F4E6-B156-43D8-A522-755805AB70EB
P50
description
researcher
@en
name
R Bernabei
@en
R Bernabei
@nl
type
label
R Bernabei
@en
R Bernabei
@nl
prefLabel
R Bernabei
@en
R Bernabei
@nl
P106
P31
P496
0000-0002-9197-004X